Region: Global
Category: Women's Health

Global Women's Health

(659 reports matching your criteria)
  • Nursing Breast Pads

    ... at a CAGR of 5.9% over the analysis period 2024-2030. Reusable Nursing Breast Pads, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$220.4 Million by the ... Read More

  • Ovulation Test

    ... CAGR of 4.0% over the analysis period 2024-2030. Urine Test, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end of the analysis ... Read More

  • Women's Health Rehabilitation Products

    ... 2030, growing at a CAGR of 1.2% over the analysis period 2024-2030. Orthopedic Rehabilitation Products, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$731.9 Million by ... Read More

  • Family Planning Centers

    ... at a CAGR of 3.3% over the analysis period 2024-2030. Birth Control Clinics, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$4.5 Billion by the end ... Read More

  • Microwave Ablation

    ... CAGR of 13.2% over the analysis period 2024-2030. Liver Cancer Application, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$215.5 Million by the end of the ... Read More

  • Breastfeeding Accessories

    ... CAGR of 6.6% over the analysis period 2024-2030. Breastmilk Storage & Feeding, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$974.4 Million by the end of ... Read More

  • Breast Cancer Therapeutics

    ... at a CAGR of 12.3% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$74.9 Billion by the end of ... Read More

  • Cervical Dysplasia Diagnostics

    ... at a CAGR of 5.9% over the analysis period 2024-2030. Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$793.8 Million by the end of ... Read More

  • Emergency Contraceptive Pills

    ... at a CAGR of 2.4% over the analysis period 2024-2030. Combination Pills, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$484.2 Million by the end of ... Read More

  • Artificial Insemination

    ... CAGR of 7.2% over the analysis period 2024-2030. Intrauterine Insemination, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$2.8 Billion by the end of the analysis ... Read More

  • Human Reproductive Technologies

    ... at a CAGR of 2.2% over the analysis period 2024-2030. Contraceptive Drugs & Devices Technology, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$22.0 Billion by ... Read More

  • Assisted Reproductive Technology

    ... at a CAGR of 4.9% over the analysis period 2024-2030. In-Vitro Fertilization (IVF), one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$22.0 Billion by the end ... Read More

  • Cervical Cancer Diagnostic Testing

    ... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Pap Smear Test, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$5.3 Billion by ... Read More

  • Endometrial Ablation Devices

    ... at a CAGR of 5.6% over the analysis period 2024-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$628.5 Million by the end of ... Read More

  • Breast Biopsy Devices

    ... at a CAGR of 5.6% over the analysis period 2024-2030. Biopsy Guidance Systems, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$983.4 Million by the end ... Read More

  • Intrauterine Devices

    ... CAGR of 3.8% over the analysis period 2024-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the ... Read More

  • In-Vitro Fertilization

    ... CAGR of 8.0% over the analysis period 2024-2030. In-Vitro Fertilization Equipment, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$684.2 Million by the end of the ... Read More

  • Global Pregnancy Skincare Products Competitive Landscape Professional Research Report 2025

    ... dryness, acne, pigmentation issues (like melasma or "pregnancy mask"), and stretch marks. Pregnancy-safe skincare products are free from ingredients that are known to be potentially harmful to pregnant individuals or their developing babies, such as ... Read More

  • Global Ovarian Cancer Drugs Market - 2024-2032

    ... during the forecast period 2024-2031. Ovarian cancer is the growth of abnormal cancerous cells in the ovaries, fallopian tube, or peritoneum- the major parts of the woman’s reproductive system. Ovaries are made up of different ... Read More

  • Global Breast Biopsy Devices Market - 2025 - 2033

    ... of 6.1% during the forecast period 2025-2033. A breast biopsy is a medical procedure that includes removing a tiny sample of breast tissue for diagnostic purposes. This treatment is necessary to determine whether a concern ... Read More

  • Global Hormone Replacement Therapy Market - 2024 - 2032

    ... of 6.1% during the forecast period 2024-2032. Hormone Replacement Therapy (HRT) is a treatment that involves the use of hormones to address symptoms linked to hormonal imbalances, particularly during menopause, as well as in conditions ... Read More

  • Breast Implants Global Market Report 2025

    ... plc; HansBiomed Corp.; Establishment Labs Holdings Inc.; Silimed Indústria de Implantes Ltda. Breast Implants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need ... Read More

  • Assisted Reproductive Technology Global Market Report 2025

    ... End-User: Hospitals; Fertility ClinicsCovering: Cooper Surgical Inc.; Ferring Pharmaceuticals Ltd.; Hamilton Thorne Ltd.; Merck KGaA; Genea Limited Assisted Reproductive Technology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management ... Read More

  • 2025 Global Forecast for Breast Cancer Liquid Biopsy Market (2026-2031 Outlook)-High Tech Outlook Report

    ... The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD ... Read More

  • 2025 Global Forecast for Breast Mri Screening System Market (2026-2031 Outlook)-High Tech Outlook Report

    ... The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings